[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Infections and deaths after vaccination", "description": "E mail from CDC to CNN, Breakthrough infections\n\nhttps://www.medscape.com/viewarticle/949381?src=wnl_edit_tpal&uac=127834AR&impID=3316056&faf=1\n\nhttps://edition.cnn.com/2021/04/14/health/breakthrough-infections-covid-vaccines-cdc/index.html\n\nVaccinated people who become infected = 5,800\n\nAbout 1 in 13,275\n\nAt least 14 days after their final dose\n\nAsymptomatic, 29%\n\nRequired hospitalization = 396 (1 in 194,444)\n\nDeaths = 74 (1 in 1,040,540)\n\nCDC currently investigating factors\n\nMay be more cases to report due to reporting lag\n\nFrom 77 million fully vaccinated\n\n(Fully vaccinated as of today = 80.6 million)\n\nFrom trials\n\nPfizer/BioNTech, 95% effective in preventing symptomatic disease\n\nModerna, 94% effective in preventing symptomatic illness\n\nJohnson & Johnson, 72% from US data\n\nCharacteristics of breakthroughs so far\n\n40% of the infections were in people 60 or more\n\n65%, were female\n\nCDC is monitoring reported cases for clustering by patient demographics, geographic location, time since vaccination, vaccine type or lot number, and SARS-CoV-2 lineage\n\nCDC also continues to recommend people who have been fully vaccinated should keep taking precautions in public places, like wearing a mask, staying at least six feet apart from others, avoiding crowds and poorly ventilated spaces, and washing their hands often\n\nDr. Carlos del Rio, Emory University School of Medicine\n\nLess transmission means fewer breakthrough cases\n\nThere is currently a lot of transmission in many parts of the country\n\nVaccines will help decrease that\n\nGet vaccinated as soon as you can and help control this pandemic\n\nNational Institutes of Health Director Dr Francis Collins\n\nAllow more time for scientists to investigate links between the vaccine and blood clots\n\nand whether or not certain groups of people are more susceptible\n\nIndia, double mutation variant emerge\n\nHey john thanks for the update. I am from Delhi, India and I have contracted the virus. Situation in India is very bad. Most of the hospitals are already exhausted and many people are dying without treatment.\n\n The India variant, B.1.617\n\nE484Q and L452R\n\nFirst reported in India, late 2020\n\nAparna Mukherjee, Indian Council of Medical Research\n\nhas not been stamped as a \u2018variant of concern\u2019 so as to say that it is more lethal or more infectious\n\nBut\n\nhttps://www.healio.com/news/infectious-disease/resources/outbreak-tracker\n\nVery low prevalence in January\n\nApril, 52% of samples sequenced\n\nMaharashtra state, 60%\n\nHas been detected in 10 other countries, US, UK (77 cases) Australia and New Zealand\n\n(L452 from US data, 20% more transmissible, reduces antibody efficacy by more 50%)\n\nWilliam A. Haseltine, former professor, Harvard Medical School\n\nThe B.1.617 variant has all the hallmarks of a very dangerous virus\n\nWe must do all that is possible to identify its spread and to contain it\n\nBrazil\n\nhttps://www.washingtonpost.com/nation/2021/04/16/coronavirus-covid-live-updates-us/\n\nTrying to get more drugs from Spain\n\nRio de Janeiro, health-care workers forced to intubate patients without sedatives\n\nMechanical restraints and neuromuscular blockers\n\nDoctors Without Borders\n\nMore than 12 months into Brazil\u2019s covid-19 emergency, there is still no effective, centralized and coordinated public health response to the outbreak\n\nThe lack of political will to adequately respond to the pandemic is killing Brazilians in their thousands", "link": "https://www.youtube.com/watch?v=dr7AO2NvalI", "date_published": "2021-04-17 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Compared vaccine adverse effects", "description": "India\n\nhttps://www.mohfw.gov.in\n\nCases, + 216,850\n\nDeaths, + 1,183 = 174,308\n\nVaccinations, 117,223,509\n\nhttps://www.bbc.co.uk/news/av/world-asia-india-56747867\n\nInfection drivers\n\nWorkplaces\n\nMarkets and malls have reopened\n\nTransport operating at full capacity\n\nBig weddings\n\nFestivals\n\nElection rallies\n\nProbable new variants\n\nIsrael\n\nPopulation 9.3 million\n\n\nUS and UK vaccination rates \n\n UK, 48% of overall population\n\nI guess the difference won't bother most news consumers much but I'd like to think your viewers might be more discerning, (Tony)\n\nCerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID -19 cases and a comparison with 489,871 people receiving a COVID -19 mRNA vaccine\n\nCan help contextualize the risks and benefits of vaccination in this regard\n\nhttps://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines\n\nhttps://osf.io/a9jdq/\n\nUsing an electronic health records network\n\nAbsolute incidence of cerebral venous thrombosis (CVT) in the two weeks following:\n\n(Incidence of portal vein thrombosis, PVT also assessed)\n\nCOVID-19 diagnosis (N=513,284)\n\nInfluenza (N=172,742)\n\nReceipt of the BNT162b2 (Pfizer) or mRNA-1273 (Moderna) COVID-19 vaccines (N=489,871)\n\nThe incidence of CVT after COVID-19 diagnosis\n\nCVT = 39.0 per million people\n\nThe incidence of CVT after influenza diagnosis\n\nCVT = Zero per million people\n\nIncidence of CVT after receiving BNT162b2 or mRNA-1273 vaccine\n\nCVT = 4.1 per million people\n\nThe incidence of PVT after COVID-19 diagnosis\n\nPVT = 436\n\nThe incidence of PVT after influenza diagnosis\n\nPVT = 98\n\nIncidence of PVT after receiving BNT162b2 or mRNA-1273 vaccine\n\nPVT = 44 per million\n\nCVT incidence observed across the entire health records network\n\n0.41 per million people over any 2-week period\n\nLaboratory test results, available in a subset of the COVID-19 patients, suggestive of:\n\nRaised D-dimer, lowered fibrinogen, and an increased rate of thrombocytopenia in the CVT and PVT groups\n\nCVT Mortality = 20% in 2 weeks after CoViD\nPVT mortality = 18.8% in 2 weeks after CoViD\n\nLatest estimate from the European Medicines Agency\n\nIncidence associated with ChAdOx1 nCoV-19 vaccine \n\nCVT = 5.0 per million people\n\nSplanchnic thrombosis by the EMA following vaccination with ChAdOx1\n\n(portal, splenic, mesenteric)\n\n53 cases out of 34 million people\n\n1.6 per million people", "link": "https://www.youtube.com/watch?v=_jFYrpAkQwA", "date_published": "2021-04-16 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]